SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001479290-18-000080
Filing Date
2018-05-11
Accepted
2018-05-11 20:30:52
Documents
1
Period of Report
2018-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_152608499215478.html 4  
1 FORM 4 wf-form4_152608499215478.xml 4 5885
  Complete submission text file 0001479290-18-000080.txt   7229
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTERMUNE, INC. 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address
Russell Angus C. (Reporting) CIK: 0001534002 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 18828476